Here it should be mentioned that upregulated PSMB8/9 expression correlated with increased efficacy of immune checkpoint inhibitors in melanoma (Kalaora et al., 2020) and lower-grade glioma (Liu et al., 2022). The gene discussed is PSMB8; the disease is glioma.